Short-term proton pomp inhibitor treatment may cause hypomagnesemia in critically ill patients: a pilot study

Łukasz Krzych; Piotr Łój; Teresa Nowak; Wojciech Kazura; Piotr Knapik

doi:10.18388/abp.2017_1505

Łukasz Krzych Department of Anaesthesiology and Intensive Care, School of Medicine in Katowice, Medical University of Silesia, Katowice 14 Medyków Street, 40752 Katowice, Poland, tel/fax. 0048 327894202
Piotr Łój
Teresa Nowak
Wojciech Kazura
Piotr Knapik

DOI: https://doi.org/10.18388/abp.2017_1505

Keywords: proton-pump inhibitors, hypomagnesemia, critically ill

Abstract

Many studies have suggested a link between long-term PPI treatment and hypomagnesemia, none of them investigated the short-term exposure in high-risk patients. We sought to investigate this issue in 90 critically ill patients. We assessed serum Mg concentrations, necessity of Mg supplementation, PPI dose, duration of PPI therapy and route of administration. In multiple analysis we found that Mg supplementation (positive effect/ p=0.03) and enteral route of PPI administration (negative effect/ p=0.02) had significant impact on Mg concentration. Although deleterious relationship between short-term PPI treatment and Mg concentration was found, further studies should be provided to confirm this interesting effect.

Author Biography

Łukasz Krzych, Department of Anaesthesiology and Intensive Care, School of Medicine in Katowice, Medical University of Silesia, Katowice 14 Medyków Street, 40752 Katowice, Poland, tel/fax. 0048 327894202

Department of Anaesthesiology and Intensive Care, School of Medicine in Katowice

References

Bai JP, Hausman E, Lionberger R, Zhang X. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium. Mol Pharm 2012; 9: 3495- 505.

Danziger J, William JH, Scott DJ, Lee J, Lehman LW, Mark RG, Howell MD, Celi LA, Mukamal KJ. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013 Apr;83(4):692-9. doi: 10.1038/ki.2012.452.

El-Charabaty E, Saifan C, Abdallah M, Naboush A, Glass D, Azzi G, Azzi Y, Khan A, Baydoun H, Rondla C, Parekh N, El-Sayegh S. Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias. Int J Gen Med. 2013 Jun 28;6:515-8. doi: 10.2147/IJGM.S46932.

Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006; 355: 1834-6.

Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010 Jul;56(1):112-6. doi: 10.1053/j.ajkd.2009.11.019.

Kieboom BC, Kiefte-de Jong JC, Eijgelsheim M, Franco OH, Kuipers EJ, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study. Am J Kidney Dis. 2015 Nov;66(5):775-82. doi: 10.1053/j.ajkd.2015.05.012.

Krag M, Perner A, Moller MH. Stress ulcer prophylaxis in the intensive care unit. Curr Opin Crit Care. 2016 Apr;22(2):186-90.

Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One. 2014 Nov 13;9(11):e112558. doi: 10.1371/journal.pone.0112558.

Toh JW, Ong E, Wilson R. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterol Rep (Oxf) 2015; 3: 243-53.

William JH, Danziger J. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review. J Clin Pharmacol. 2016 Jun;56(6):660-8. doi: 10.1002/jcph.672.

William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms. World J Nephrol. 2016 Mar 6;5(2):152-7. doi: 10.5527/wjn.v5.i2.152.

Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, Lathia N, Juurlink DN. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study. PLoS Med. 2014 Sep 30;11(9):e1001736. doi: 10.1371/journal.pmed.1001736.